-
Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.
Chemical research in toxicology 20170515
-
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Chemical research in toxicology 20150518
-
Assessing the cardiovascular risk between celecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis.
Circulation journal : official journal of the Japanese Circulation Society 20140101
-
Cyclooxygenase 2 and prostaglandin E2 regulate the attachment of calcium oxalate crystals to renal epithelial cells.
International journal of urology : official journal of the Japanese Urological Association 20121001
-
Renal effects of carprofen and etodolac in euvolemic and volume-depleted dogs.
American journal of veterinary research 20120901
-
Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.
The Journal of pharmacology and experimental therapeutics 20120701
-
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
European journal of medicinal chemistry 20120701
-
The effect of renal administration of a selective cyclooxygenase-2 inhibitor or stable prostaglandin I2 analog on the progression of sclerotic glomerulonephritis in rats.
Clinical and experimental nephrology 20120401
-
Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations.
Journal of fluorescence 20120101
-
Etodolac blocks the allyl isothiocyanate-induced response in mouse sensory neurons by selective TRPA1 activation.
Pharmacology 20120101
-
The effects of the selective cyclooxygenase-2 inhibitor on endometrial cytological findings in uterine endometrial cancer patients.
Acta cytologica 20120101
-
Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers.
Archives of gynecology and obstetrics 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Comparative evaluation of efficacy and safety of etodolac and diclofenac sodium injection in patients with postoperative orthopedic pain.
Current medical research and opinion 20111101
-
Acute generalized exanthematous pustulosis due to etodolac in a patient with an iliopsoas muscle abscess.
Acta dermato-venereologica 20110901
-
Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.
Anticancer research 20110901
-
The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.
International journal of clinical pharmacology and therapeutics 20110901
-
In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
British journal of cancer 20110726
-
Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
Clinical cancer research : an official journal of the American Association for Cancer Research 20110601
-
Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.
AAPS PharmSciTech 20110601
-
Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses.
Annals of surgery 20110401
-
High specific activity tritiation of several biologically active indoles.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110201
-
Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.
Biological & pharmaceutical bulletin 20110101
-
The enantiomers of etodolac, a racemic anti-inflammatory agent, play different roles in efficacy and gastrointestinal safety.
Biological & pharmaceutical bulletin 20110101
-
Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats.
International journal of colorectal disease 20101201
-
R-etodolac induces E-cadherin and suppresses colitis-related mouse colon tumorigenesis.
Oncology reports 20101201
-
Polymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation.
AAPS PharmSciTech 20101201
-
Transcription factor NF-ÎşB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.
Current molecular pharmacology 20101101
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
Singapore medical journal 20101101
-
Efficacy and safety of etodolac-paracetamol fixed dose combination in patients with knee osteoarthritis flare-up: a randomized, double-blind comparative evaluation.
The Clinical journal of pain 20100901
-
A multicentric, randomized, comparative clinical trial to evaluate the efficacy and safety of S-etodolac in the treatment of osteoarthritis in Indian patients.
International journal of clinical pharmacology and therapeutics 20100701
-
In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
Research in veterinary science 20100601
-
Sacroiliitis and severe disability due to isotretinoin therapy.
Rheumatology international 20100501
-
Profiling of cell cycle genes of breast cells exposed to etodolac.
Oncology reports 20100501
-
Blurred vision and weakness in a 60-year-old woman.
The American journal of emergency medicine 20100501
-
Chemopreventive activities of etodolac and oxyphenbutazone against mouse skin carcinogenesis.
Bioorganic & medicinal chemistry letters 20100415
-
Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion.
International journal of cancer 20100315
-
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
Journal of immunology (Baltimore, Md. : 1950) 20100301
-
The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb model.
European journal of pharmacology 20100210
-
Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation.
The Journal of pharmacy and pharmacology 20100201
-
Crystal and molecular structure of beta-cyclodextrins functionalized with the anti-inflammatory drug Etodolac.
Biopolymers 20091201
-
Preparative resolution of etodolac enantiomers by preferential crystallization method.
Archives of pharmacal research 20091001
-
In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac.
AAPS PharmSciTech 20090901
-
Racemic Etodolac is cytotoxic and cytostatic for B-cell precursor acute lymphoblastic leukemia cells.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090801
-
Reversible cerebral vasoconstriction syndrome: case report.
The journal of headache and pain 20090801
-
Evidence-based review of clinical studies on pharmacology (non-anesthetic studies).
Journal of endodontics 20090801
-
Paradoxical effects of a selective cyclooxygenase-2 inhibitor, etodolac, on proliferative changes of forestomach in alloxan-induced diabetic rats.
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20090701
-
Etodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies.
Drug development and industrial pharmacy 20090701
-
Inhibitory effect of nonsteroidal anti-inflammatory drugs on adenosine transport in vascular smooth muscle cells.
European journal of pharmacology 20090610
-
Etodolac attenuates mechanical allodynia in a mouse model of neuropathic pain.
Journal of pharmacological sciences 20090401
-
Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
Current eye research 20090301
-
The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis.
Spine 20090115
-
Single dose oral etodolac for acute postoperative pain in adults.
The Cochrane database of systematic reviews 20090101
-
Dextran-etodolac conjugates: synthesis, in vitro and in vivo evaluation.
Acta poloniae pharmaceutica 20090101
-
COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma.
Journal of investigational allergology & clinical immunology 20090101
-
The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
Journal of cardiovascular pharmacology and therapeutics 20081201
-
Improvement of the etodolac purity test by reversed phase high-performance liquid chromatography.
Die Pharmazie 20081201
-
The effects of etodolac, nimesulid and naproxen sodium on the frequency of sister chromatid exchange after enclused third molars surgery.
Yonsei medical journal 20081031
-
Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.
Metabolic brain disease 20080901
-
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents.
Bioorganic & medicinal chemistry 20080901
-
Determination of enantiomeric impurity of etodolac by capillary electrophoresis using (2-hydroxypropyl)-beta-cyclodextrin.
Archives of pharmacal research 20080901
-
Chiral non-steroidal anti-inflammatory drugs--a review.
Journal of the Indian Medical Association 20080901
-
The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.
Leukemia & lymphoma 20080801
-
In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.
Basic & clinical pharmacology & toxicology 20080801
-
Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.
Bioorganic & medicinal chemistry 20080601
-
Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
Journal of pharmaceutical and biomedical analysis 20080414
-
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.
Investigational new drugs 20080401
-
Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.
Carcinogenesis 20080401
-
Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice.
Neuroscience 20080318
-
Development and validation of a high performance liquid chromatography-tandem mass spectrometry for the determination of etodolac in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080215
-
Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.
Oncology reports 20080201
-
Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
Urology 20080101
-
Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations.
Chemistry Central journal 20080101
-
Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma.
Anticancer research 20080101
-
Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs.
Redox report : communications in free radical research 20080101
-
Use of liposomes as membrane models to evaluate the contribution of drug-membrane interactions to antioxidant properties of etodolac.
Redox report : communications in free radical research 20080101
-
The effect of etodolac on experimental temporomandibular joint osteoarthritis in dogs.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20071201
-
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Cancer research 20071101
-
SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma.
Archiv der Pharmazie 20071001
-
In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers.
Drug delivery 20071001
-
More than meets the eyes.
Journal of the Mississippi State Medical Association 20071001
-
R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
Cancer chemotherapy and pharmacology 20070901
-
Treatment of multiple myeloma with SDX-308.
Drug news & perspectives 20070901
-
Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro.
Investigational new drugs 20070801
-
Etodolac-induced pigmenting fixed drug eruption.
Clinical and experimental dermatology 20070501
-
R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
Journal of hepatology 20070501
-
One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
Transfusion 20070401
-
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway.
Leukemia 20070301
-
Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.
The Journal of dermatology 20070301
-
Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs.
American journal of veterinary research 20070301
-
Keratoconjunctivitis sicca associated with administration of etodolac in dogs: 211 cases (1992-2002).
Journal of the American Veterinary Medical Association 20070215
-
Pharmacokinetics of etodolac in the horse following oral and intravenous administration.
Journal of veterinary pharmacology and therapeutics 20070201
-
Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream.
Cancer letters 20070108
-
Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1).
Oncology reports 20070101
-
Membranous nephropathy associated with the relatively selective cyclooxygenase-2 inhibitor, etodolac, in a patient with early rheumatoid arthritis.
Internal medicine (Tokyo, Japan) 20070101
-
Charge transfer complex studies between some non-steroidal anti-inflammatory drugs and pi-electron acceptors.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20061201
-
Non-steroidal anti-inflammatory drug therapy for chronic lymphocytic leukemia.
Leukemia & lymphoma 20061201
-
Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
Leukemia & lymphoma 20061201
-
Effects of cyclooxygenase inhibition on the gastrointestinal tract.
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20061101
-
Involvement of cyclooxygenase-2 in allergic nasal inflammation in rats.
International immunopharmacology 20061101
-
Case of the month. Chronic hepatitis.
JAAPA : official journal of the American Academy of Physician Assistants 20061101
-
The clinical pharmacology of cyclooxygenase-2-selective and dual inhibitors.
The Veterinary clinics of North America. Small animal practice 20060901
-
Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.
Cancer science 20060801
-
Etodolac-liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulation.
Drug development and industrial pharmacy 20060801
-
High-grade slippage of the lumbar spine in a rat model of spondylolisthesis: effects of cyclooxygenase-2 inhibitor on its deformity.
Spine 20060715
-
In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
British journal of haematology 20060701
-
Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Cancer research 20060615
-
Etodolac versus dexamethasone effect in reduction of postoperative symptoms following surgical endodontic treatment: a double-blind study.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20060601
-
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
-
Depressed-type early invasive colon cancer in a patient treated with cyclooxygenase-2 inhibitor.
Digestive diseases and sciences 20060501
-
Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors.
Neuroscience research 20060401
-
Use of force plate analysis to assess the analgesic effects of etodolac in horses with navicular syndrome.
American journal of veterinary research 20060401
-
[Intestinal side effects of COX-2 inhibitors].
Ugeskrift for laeger 20060327
-
Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.
Leukemia research 20060201
-
Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
International journal of molecular medicine 20060201
-
Ocular adverse effects associated with cyclooxygenase-2 inhibitors.
Archives of ophthalmology (Chicago, Ill. : 1960) 20060201
-
[Expression of cyclooxygenase (COX)-2 in astrocytic tumors and anti-tumor effects of selective COX-2 inhibitors].
No to shinkei = Brain and nerve 20060101
-
Efficacy and safety of preoperative etodolac and butorphanol administration in dogs undergoing ovariohysterectomy.
Journal of the American Animal Hospital Association 20060101
-
[Postoperative pain management in clinics of otolaryngology].
Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat 20060101
-
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
Drug safety 20060101
-
Poststreptococcal reactive arthritis.
Journal of the American Podiatric Medical Association 20060101
-
Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
Veterinary therapeutics : research in applied veterinary medicine 20060101
-
Combined administration of ethodolac, ascorbic acid and radiotherapy as adjuvant therapies in an extrathoracic desmoid tumor with gross postoperative residual disease; case report and review of the literature.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20060101
-
Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
Pathobiology : journal of immunopathology, molecular and cellular biology 20060101
-
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
Bioorganic & medicinal chemistry letters 20051201
-
Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo.
Urology 20051201
-
Prostaglandin production during growth of Candida albicans biofilms.
Journal of medical microbiology 20051101
-
An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices.
Journal of pharmaceutical and biomedical analysis 20050915
-
Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
Biochemical pharmacology 20050901
-
Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.
European journal of haematology 20050901
-
Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils.
Biochemical and biophysical research communications 20050826
-
Cyclooxygenase-2 inhibitor delays fracture healing in rats.
Acta orthopaedica 20050801
-
SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.
Blood 20050715
-
Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
International journal of oncology 20050501
-
In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis.
American journal of veterinary research 20050501
-
Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
Research in veterinary science 20050401
-
Separation of etodolac enantiomers by capillary electrophoresis. Validation and application of the chiral method to the analysis of commercial formulations.
Electrophoresis 20050301
-
The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis.
Proceedings of the National Academy of Sciences of the United States of America 20050215
-
Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters.
Carcinogenesis 20050201
-
Etodolac, a selective cyclo-oxygenase-2 inhibitor, enhances carboplatin-induced apoptosis of human tongue carcinoma cells by down-regulation of FAP-1 expression.
Oral oncology 20050101
-
Anti-inflammatory, antinociceptive, and gastric effects of Hypericum perforatum in rats.
TheScientificWorldJournal 20050101
-
Nonsteroidal antiinflammatory drugs: a review.
Journal of the American Animal Hospital Association 20050101
-
Effects of etodolac on P450 isoform-specific activities in human hepatic microsomes.
Arzneimittel-Forschung 20050101
-
Spectrophotometric study of etodolac complexes with copper (II) and iron (III).
Journal of AOAC International 20050101
-
COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.
Biochemical and biophysical research communications 20041210
-
Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20041201
-
Carboxyl nonsteroidal anti-inflammatory drugs are efficiently glucuronidated by microsomes of the human gastrointestinal tract.
Biochimica et biophysica acta 20041118
-
Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis.
Gastroenterology 20041101
-
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
Journal of medicinal chemistry 20040923
-
Warning of an adverse effect of etodolac.
Journal of the American Veterinary Medical Association 20040815
-
Adverse drug event reports at the United States Food And Drug Administration Center for Veterinary Medicine.
Journal of the American Veterinary Medical Association 20040815
-
Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines.
Cancer science 20040801
-
Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
Acta pharmacologica Sinica 20040801
-
Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model.
Brain research 20040604
-
Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma.
Cancer cell 20040601
-
Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemia.
American journal of veterinary research 20040601
-
Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs.
American journal of veterinary research 20040601
-
[A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy].
Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 20040601
-
Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats.
Oncology reports 20040501
-
Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man.
Xenobiotica; the fate of foreign compounds in biological systems 20040501
-
MCF-7 breast cancer cell line grown in agarose culture for study of COX-2 inhibitors in three-dimensional growth system.
Cancer letters 20040308
-
Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
The Journal of rheumatology 20040301
-
Sequence-dependent effect of a cyclooxygenase-2 inhibitor on topoisomerase I inhibitor and 5-fluorouracil-induced cytotoxicity of colon cancer cells.
Anti-cancer drugs 20040301
-
Efficacy of transdermal nitroglycerin combined with etodolac for the treatment of chronic post-thoracotomy pain: an open-label prospective clinical trial.
Journal of pain and symptom management 20040301
-
Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer.
Oncology reports 20040101
-
Secondary hypertrophic osteoarthropathy (HOA) mimicking primary HOA (pachydermoperiostitis or Touraine-Solente-Golé) syndrome.
The Israel Medical Association journal : IMAJ 20040101
-
Oral etodolac, a COX-2 inhibitor, reduces postoperative pain immediately after fast-track cardiac surgery.
Journal of anesthesia 20040101
-
In vitro effects of selective and non-selective nonsteroidal anti-inflammatory drugs on the frequency of sister chromatid exchanges.
Drugs in R&D 20040101
-
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Journal of medicinal chemistry 20031009
-
Effects of a single arthrocentesis and a COX-2 inhibitor on disorders of temporomandibular joints. A preliminary clinical study.
The British journal of oral & maxillofacial surgery 20031001
-
Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide.
Cancer letters 20030925
-
[Combined treatment with fluorinated pyrimidines and selective cyclooxygenase-2 inhibitors for liver metastasis of colon cancer].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Pharmacology 20030601
-
Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor.
Cancer science 20030301
-
Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors.
Alimentary pharmacology & therapeutics 20030201
-
Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial.
The Annals of thoracic surgery 20030201
-
Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
Current medical research and opinion 20030101
-
Superficially elevated colonic adenoma changed to undetectable configuration on ordinary endoscopy during treatment with preferential cyclooxygenase-2 inhibitor.
Journal of gastroenterology 20030101
-
Effect of dosing and sampling time on serum thyroxine, free thyroxine, and thyrotropin concentrations in dogs following multidose etodolac administration.
Veterinary therapeutics : research in applied veterinary medicine 20030101
-
A study of the comparative efficacy of three common analgesics in the control of pain after third molar surgery under local anaesthesia.
Australian dental journal 20021201
-
Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells.
FEBS letters 20021106
-
Results of thyroid function tests and concentrations of plasma proteins in dogs administered etodolac.
American journal of veterinary research 20021101
-
In vitro investigation of the effects of cyclooxygenase-2 inhibitors on contractile activity of the equine dorsal and ventral colon.
American journal of veterinary research 20021101
-
Cyclooxygenase-2 inhibitor inhibits the fracture healing.
Journal of physiological anthropology and applied human science 20020901
-
The effects of cyclo-oxygenase inhibitors on bile-injured and normal equine colon.
Equine veterinary journal 20020701
-
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
The Journal of biological chemistry 20020419
-
Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac.
Blood 20020401
-
Regulation of prostaglandin production in an immortalized human myometrial cell line by cytokines and non-steroidal anti-inflammatory drugs.
European journal of obstetrics, gynecology, and reproductive biology 20020110
-
Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
Journal of gastroenterology 20020101
-
Search of antimicrobial activity of selected non-antibiotic drugs.
Acta poloniae pharmaceutica 20020101
-
Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes.
The Journal of pharmacy and pharmacology 20011201
-
Regioselective biomimetic oxidation of etodolac with iodosylbenzene catalyzed by halogenated and perhalogenated metalloporphyrins in dichloromethane.
Chemical & pharmaceutical bulletin 20011001
-
Nonsteroidal anti-inflammatory drugs for perioperative pain control.
Medicine and health, Rhode Island 20011001
-
Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs.
The Journal of veterinary medical science 20011001
-
Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction?
The Journal of urology 20010901
-
Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation.
European journal of pharmacology 20010824
-
Long-term temporal evaluation of ground reaction forces during development of experimentally induced osteoarthritis in dogs.
American journal of veterinary research 20010801
-
Isolation of an unknown metabolite of the non-steroidal anti-inflammatory drug etodolac and its identification as 5-hydroxy etodolac.
Journal of pharmaceutical and biomedical analysis 20010701
-
Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines.
International journal of urology : official journal of the Japanese Urological Association 20010701
-
Effects of cyclooxygenase-2 inhibitor on gastric acid secretion in Helicobacter pylori-infected C57BL/6 mice.
Scandinavian journal of gastroenterology 20010601
-
Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.
International journal of cancer 20010315
-
Direct superoxide scavenging activity of nonsteroidal anti-inflammatory drugs: determination by electron spin resonance using the spin trap method.
Headache 20010201
-
[Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
The Japanese journal of antibiotics 20010201
-
Nimesulide, a balanced drug for the treatment of osteoarthritis.
Clinical and experimental rheumatology 20010101
-
The role of eicosanoids in the process of adaptation following massive bowel resection in the rat.
JPEN. Journal of parenteral and enteral nutrition 20010101
-
The effect of etodolac on bile salt and histamine-mediated gastric mucosal injury in the rat.
Journal of physiology, Paris 20010101
-
Effects of some pharmacological agents on the survival of unipedicled venous flaps: an experimental study.
Microsurgery 20010101
-
Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.
Gut 20001201
-
Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug.
Transfusion 20000601
-
The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts.
Alimentary pharmacology & therapeutics 20000401
-
Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells.
European journal of pharmacology 19991103
-
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
British journal of pharmacology 19970501
-
Nonsteroidal antiinflammatory drug induced hypersensitivity vasculitis clinically mimicking temporal arteritis.
The Journal of rheumatology 19960101
-
Fulminant hepatic failure associated with etodolac use.
The American journal of gastroenterology 19950401
-
Anti-inflammatory effects of etodolac: comparison with other non-steroidal anti-inflammatory drugs.
Biological & pharmaceutical bulletin 19941201
-
Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease (osteoarthritis) in its active phase.
International journal of clinical pharmacology research 19940101
-
[Allergic vasculitis caused by etodolac. The first case].
Annales de medecine interne 19890101
-
Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesis.
Inflammation 19841201